Detail page

Knowledge Web

Person

Sherko Kümmel (1971-)

Facharzt

Name	Sherko Kümmel
Time	1971- (Date of birth and death)
Place	Berlin (Geburtsort) Essen (Wirkungsort) Deutschland
Academic degree	PD Dr. med.
Profession	Facharzt (characteristic profession) Gynäkologe
Variant	Sherko Kuemmel
Further information	Seit 2010: Direktor der Klinik für Senologie/Brustzentrum Kliniken Essen-Mitte
Source	Internet: http://www.kliniken-essen-mitte.de/fileadmin/user_upload/Dokumente_PDF/Senologie/Curriculum_Vitae_Kuemmel.pdf
Record type	Person
GND-Identifier	122704142
Record ID	122704142
Involved in show all Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2024 ASO Visual Abstract: Minimally-Invasive Breast Biopsy After Neoadjuvant Systemic Treatment to Identify Breast Cancer Patients with Residual Disease for Extended Neoadjuvant Treatment—A New Concept Minimally Invasive Breast Biopsy After Neoadjuvant Systemic Treatment to Identify Breast Cancer Patients with Residual Disease for Extended Neoadjuvant Treatment: A New Concept AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2021 AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer : update 2021 Immune cell composition and functional marker dynamics from multiplexed immunohistochemistry to predict response to neoadjuvant chemotherapy in the WSG-ADAPT-TN trial AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer: update 2020 AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2020 Post-Mastectomy Radiotherapy After Neoadjuvant Chemotherapy in Breast Cancer: A Pooled Retrospective Analysis of Three Prospective Randomized Trials Post-mastectomy radiotherapy after neoadjuvant chemotherapy in breast cancer: a pooled retrospective analysis of three prospective randomized trials Ist eine Operation der Brust bei Komplettremission nach neoadjuvanter Chemotherapie des Mammakarzinoms notwendig? Is Breast Surgery Necessary for Breast Carcinoma in Complete Remission Following Neoadjuvant Chemotherapy? Der Einfluss der gelben Hauszwiebel (Allium cepa) im Vergleich zu den synthetischen Flavonoiden (Quercetin und Rutin) auf das Wachstumsverhalten der estrogenrezeptorpositiven Mammakarzinomzelllinie MCF-7 Is breast surgery necessary for breast carcinoma in complete remission following neoadjuvant chemotherapy? Ist eine Operation der Brust bei Komplettremission nach neoadjuvanter Chemotherapie des Mammakarzinoms notwendig? Efficacy and safety of nab-paclitaxel 125 mg/m2 and nab-paclitaxel 150 mg/m2 compared to paclitaxel in early high-risk breast cancer. Results from the neoadjuvant randomized GeparSepto study (GBG 69) Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study Interest in Integrative Medicine Among Postmenopausal Hormone Receptor – Positive Breast Cancer Patients in the EvAluate-TM Study Outcome after neoadjuvant chemotherapy in young breast cancer patients: a pooled analysis of individual patient data from eight prospectively randomized controlled trials Nab-Paclitaxel beim metastasierten Mammakarzinom : Wirkmechanismen, Studiendaten und Fallbeispiele aus der klinischen Praxis Impact of Multifocal or Multicentric Disease on Surgery and Locoregional, Distant and Overall Survival of 6,134 Breast Cancer Patients Treated With Neoadjuvant Chemotherapy Aktivně proti rakovině : klasická medicína a přírodní léčebné metody Spolu proti rakovine : prírodné liečitel'stvo a onkológia Gemeinsam gegen Krebs : Naturheilkunde und Onkologie - zwei Ärzte für eine menschliche Medizin Gemeinsam gegen Krebs : Naturheilkunde und Onkologie - zwei Ärzte für eine menschliche Medizin Clinical feasibility of (neo)adjuvant taxane-based chemotherapy in older patients: analysis of >4,500 patients from four German randomized breast cancer trials Kernspintomographie fokaler Leberläsionen mit dem neuen hepatobiliären Kontrastmittel Gd-EOB-DTPA : intraindividueller Vergleich mit dem Standardkontrastmittel Gd-DTPA

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Sherko Kümmel (1971-)

Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2024

ASO Visual Abstract: Minimally-Invasive Breast Biopsy After Neoadjuvant Systemic Treatment to Identify Breast Cancer Patients with Residual Disease for Extended Neoadjuvant Treatment—A New Concept

Minimally Invasive Breast Biopsy After Neoadjuvant Systemic Treatment to Identify Breast Cancer Patients with Residual Disease for Extended Neoadjuvant Treatment: A New Concept

AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2021

AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer : update 2021

Immune cell composition and functional marker dynamics from multiplexed immunohistochemistry to predict response to neoadjuvant chemotherapy in the WSG-ADAPT-TN trial

AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer: update 2020

AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2020

Post-Mastectomy Radiotherapy After Neoadjuvant Chemotherapy in Breast Cancer: A Pooled Retrospective Analysis of Three Prospective Randomized Trials

Post-mastectomy radiotherapy after neoadjuvant chemotherapy in breast cancer: a pooled retrospective analysis of three prospective randomized trials

Ist eine Operation der Brust bei Komplettremission nach neoadjuvanter Chemotherapie des Mammakarzinoms notwendig?

Is Breast Surgery Necessary for Breast Carcinoma in Complete Remission Following Neoadjuvant Chemotherapy?

Der Einfluss der gelben Hauszwiebel (Allium cepa) im Vergleich zu den synthetischen Flavonoiden (Quercetin und Rutin) auf das Wachstumsverhalten der estrogenrezeptorpositiven Mammakarzinomzelllinie MCF-7

Is breast surgery necessary for breast carcinoma in complete remission following neoadjuvant chemotherapy?

Ist eine Operation der Brust bei Komplettremission nach neoadjuvanter Chemotherapie des Mammakarzinoms notwendig?

Efficacy and safety of nab-paclitaxel 125 mg/m2 and nab-paclitaxel 150 mg/m2 compared to paclitaxel in early high-risk breast cancer. Results from the neoadjuvant randomized GeparSepto study (GBG 69)

Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study

Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study

Interest in Integrative Medicine Among Postmenopausal Hormone Receptor – Positive Breast Cancer Patients in the EvAluate-TM Study

Outcome after neoadjuvant chemotherapy in young breast cancer patients: a pooled analysis of individual patient data from eight prospectively randomized controlled trials

Nab-Paclitaxel beim metastasierten Mammakarzinom : Wirkmechanismen, Studiendaten und Fallbeispiele aus der klinischen Praxis

Impact of Multifocal or Multicentric Disease on Surgery and Locoregional, Distant and Overall Survival of 6,134 Breast Cancer Patients Treated With Neoadjuvant Chemotherapy

Aktivně proti rakovině : klasická medicína a přírodní léčebné metody

Spolu proti rakovine : prírodné liečitel'stvo a onkológia

Gemeinsam gegen Krebs : Naturheilkunde und Onkologie - zwei Ärzte für eine menschliche Medizin

Gemeinsam gegen Krebs : Naturheilkunde und Onkologie - zwei Ärzte für eine menschliche Medizin

Clinical feasibility of (neo)adjuvant taxane-based chemotherapy in older patients: analysis of >4,500 patients from four German randomized breast cancer trials

Kernspintomographie fokaler Leberläsionen mit dem neuen hepatobiliären Kontrastmittel Gd-EOB-DTPA : intraindividueller Vergleich mit dem Standardkontrastmittel Gd-DTPA